Read + Share
Amedeo Smart
Independent Medical Education
Fukuda K, Otani S, Takeuchi S, Arai S, et al. Trametinib overcomes KRAS-G12V-induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR-mutant lung cancer. Cancer Sci 2021 Jun 19. doi: 10.1111/cas.15035.PMID: 34145930
Email
LinkedIn
Facebook
Twitter
Privacy Policy